mTOR Inhibitor Immunosuppressant [EPC]

63135 reported adverse events

Drugs of this class: SIROLIMUS EVEROLIMUS EVEROLIMUS TABLETS

These side effects are most commonly reported by patients taking drugs of the mTOR Inhibitor Immunosuppressant [EPC] class:

# Side effect Count
0 DEATH 6689
1 MALIGNANT NEOPLASM PROGRESSION 4801
2 DIARRHOEA 4641
3 FATIGUE 4107
4 OFF LABEL USE 4008
5 DRUG INEFFECTIVE 3509
6 STOMATITIS 3387
7 NAUSEA 3182
8 DYSPNOEA 2874
9 PYREXIA 2703
See all common reactions for mTOR Inhibitor Immunosuppressant [EPC]

Drugs of the mTOR Inhibitor Immunosuppressant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PANCREATIC NEUROENDOCRINE TUMOUR 177 0.2761
1 POLYOMAVIRUS VIRAEMIA 241 0.2269
2 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 507 0.2162
3 NEUROENDOCRINE TUMOUR 227 0.1602
4 BK VIRUS INFECTION 454 0.1345
5 METASTASES TO SKIN 136 0.1317
6 VIRAEMIA 168 0.1212
7 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 495 0.0972
8 LIVER TRANSPLANT REJECTION 170 0.0945
9 TRANSPLANT REJECTION 713 0.0889
See all enriched reactions for mTOR Inhibitor Immunosuppressant [EPC]